Background: The role of radiographs in the follow-up of patients with metal-on-metal hip resurfacing (MoMHR) implants
Radiographs are considered important in the assessment of patients managed with MoMHR, as they provide information on component position, bone quality, and implant fixation 9 . Radiographs can also identify signs suggestive of implant failure early. Furthermore, in addition to blood metal ion analysis and cross-sectional imaging, radiographs are currently recommended by most 7, 8 but not all 6 medical regulatory authorities. However, given that pseudotumors can be solid or cystic lesions associated with soft-tissue damage and high wear 4, 5 , most clinicians prefer to measure blood metal ion levels and perform cross-sectional imaging rather than use radiographs [6] [7] [8] . Previous studies have reported radiographic risk factors for pseudotumors that include the implantation of acetabular components outside an optimal zone [10] [11] [12] and substantial reduction in the head-neck ratio following MoMHR 13 . These studies are limited by their small numbers of revisions for pseudotumor and their assessment of relatively few radiographic parameters [10] [11] [12] [13] . Interpretation of such studies is also complicated by observations that pseudotumors can still occur in optimally positioned MoMHRs 11, 14 . Moreover, it remains unclear whether femoral neck narrowing is a normal physiological process following MoMHR or a clinically important finding, given that neck narrowing is reported both in patients with a well-functioning MoMHR 15, 16 and in patients who have undergone revision for pseudotumor 9, 17 . The need for radiographs in the follow-up of MoMHR patients therefore remains unclear. It is important to establish the role of radiographs in MoMHR surveillance given their wide availability and low cost as well as the fact that current follow-up recommendations are not evidence-based but are costly 18 . We investigated whether a combination of patient and radiographic factors predicted MoMHRs with evidence of a pseudotumor. By using the factors identified, a clinical risk scoring tool was developed to predict a patient's risk of having a pseudotumor.
Materials and Methods

W
e performed a retrospective single-center multi-surgeon case-control study including 384 MoMHRs implanted in 329 patients (Table I) . These hips were divided into pseudotumor (case) and nonpseudotumor (control) groups. All primary MoMHRs were performed between June 1999 and December 2009. During this period, 1,429 MoMHRs in 1,216 patients were implanted at this center, with the outcomes for these patients previously described in detail 19 .
Pseudotumor Group (130 Hips)
Revision surgery of MoMHRs for pseudotumor has been performed since 2007, when this entity was first recognized 4 . By August 2015, 231 consecutive
MoMHR revisions for any indication were recorded in our prospective clinical database. The pseudotumor group for the present study included all MoMHRs revised for pseudotumor (n = 130; 56% of all revisions). All patients undergoing revision for pseudotumor were symptomatic. Of the 130 hips revised for pseudotumor, 111 (85%) had received the primary MoMHR at our institution and the remainder were referred to our center after undergoing primary resurfacing arthroplasty elsewhere. Prior to revision surgery, patients were evaluated with use of anteroposterior pelvic radiographs, blood metal ion analysis, and ultrasound, with metal artifact reduction sequence magnetic resonance imaging (MARS-MRI) reserved for equivocal or complex cases 4, 20 . The decision 
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to perform revision was made by the patient's surgeon based on the symptoms and investigative findings. All pseudotumors were diagnosed on cross-sectional imaging prior to revision surgery and subsequently confirmed intraoperatively. Pseudotumors were defined as cystic, solid, or mixed masses communicating with the hip joint 4, 21, 22 . The diagnosis of a pseudotumor was confirmed if there was also histological evidence of lymphocytic infiltrates (including aseptic lymphocytic vasculitis and associated lesions) and a phagocytic macrophage response to metal wear debris, with or without tissue necrosis [23] [24] [25] .
Nonpseudotumor Group (254 Hips)
Following alerts in 2010 and 2012 from the Medicines and Healthcare products Regulatory Agency (MHRA), all symptomatic MoMHR patients underwent clinical examination, anteroposterior pelvic radiographs, blood metal ion analysis, and cross-sectional imaging 6, 26 . In 2007 and 2008, prior to these alerts, we had investigated 201 asymptomatic MoMHRs with anteroposterior pelvic radiographs, blood metal ion analysis, and cross-sectional imaging 27 .
The nonpseudotumor group for the present study included all patients with nonrevised MoMHRs, regardless of symptoms, with normal findings on cross-sectional imaging (no evidence of a pseudotumor on ultrasound and/or MARS-MRI 
Radiographic Analysis
Standardized anteroposterior pelvic radiographs for all patients were accessed with use of the hospital's electronic picture-archiving and communication system (PACS; GE Healthcare). Apart from femoral neck narrowing measurements (which also required use of the radiograph taken immediately following primary MoMHR surgery), all radiographic parameters were assessed with use of a single radiograph for each MoMHR. For the pseudotumor group, the radiograph selected for assessment was the one taken closest to but immediately before the date of revision surgery. This represented a time when the hip was symptomatic and the pseudotumor had already been diagnosed on cross-sectional imaging. In the nonpseudotumor group, the radiograph selected for assessment was taken at the time that cross-sectional imaging excluded a pseudotumor. Each radiograph was systematically analyzed for the presence or absence of abnormalities previously described in MoMHRs, including component loosening (a radiolucent line of >2 mm in any zone), osteolysis, femoral neck notching, fracture, dislocation, subluxation, impingement, and heterotopic ossification 9, [30] [31] [32] . 
†The results were significant (p < 0.05). ‡Malposition was defined as 1 or both parameters outside the previously recommended optimal zone (inclination of 35°to 55°and anteversion of 10°to 30°) 11 .
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Acetabular component inclination (relative to the pelvic interteardrop line) and anteversion were measured with use of ImageJ software (National Institutes of Health) 33 . Acetabular components were considered malpositioned if 1 or both parameters were outside the recommended optimal zone for MoMHR (an inclination of 35°to 55°and anteversion of 10°to 30°) 11 . Femoral neck narrowing was assessed as previously described 34 . Femoral neck diameter was measured on each radiograph at the junction of the neck and the femoral component, and it was divided by the measured femoral component diameter (allowing correction for magnification). The difference between measurements from the most recent radiograph and the radiograph taken immediately following primary MoMHR allowed calculation of the degree of femoral neck narrowing since the index procedure (expressed as a percentage of the initial neck diameter).
All radiographs were assessed by 2 independent observers (G.S.M. and K.D.) in a random sequence, with both blinded to all clinical information, including the study group. For the presence or absence of different radiographic abnormalities, interobserver agreement was excellent (Cohen kappa statistic, 0.88 to 1.00) 35 . Any discrepancy regarding the presence or absence of abnormalities was settled by the senior author (H.G.P.), with this final assessment used for analyses. For continuous radiographic data, intraclass correlation coefficients between observers were excellent: 0.979 (95% confidence interval [CI], 0.955 to 0.990) for inclination, 0.968 (95% CI, 0.947 to 0.988) for anteversion, and 0.941 (95% CI, 0.861 to 0.987) for femoral neck narrowing. The mean of the 2 observer measurements was used for continuous radiographic variables.
Statistical Analysis
The study outcome of interest was a binary variable: MoMHR with or without a pseudotumor. The influence of patient factors (sex, age, and implant design) and radiographic factors (noted earlier) were assessed between groups. Numerical data were compared between groups using either unpaired t tests (parametric data) or the Wilcoxon rank-sum test (nonparametric data), with *CI = confidence interval, BHR = Birmingham Hip Resurfacing, and NA = not applicable. Impingement and acetabular fracture were not analyzed, as no events occurred in the whole cohort. The effect of acetabular component anteversion (p value for nonlinearity = 0.0144) on outcome was nonlinear; therefore, this covariate was categorized. The effects of both patient age at the time of radiography (p value for nonlinearity = 0.937) and acetabular component inclination (p value for nonlinearity = 1.0) on outcome were linear; therefore, these covariates were analyzed as continuous variables. †The results were significant (p < 0.05). ‡Not included. The final multivariable logistic regression model includes only patient and radiographic factors for which p < 0.10.
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categorical data compared using either the chi-squared test with Yates' correction or Fisher's exact test. Logistic regression modeling was used to identify predictors of outcome. Univariable models explored the association between each predictor and outcome. For continuous predictors, linearity was assessed using likelihood ratio tests, with data categorized if the relationship between a predictor and the outcome was nonlinear. A multivariable logistic regression model was formulated using backward selection, with patient and radiographic predictors retained in the final model if p < 0.10. Regression diagnostics were assessed to ensure that all assumptions underlying the model were met 36, 37 . Internal validation of the final multivariable model was performed, including calibration, discrimination, and bootstrapping (see Appendix) [37] [38] [39] . Patient and radiographic factors from the final multivariable model were formulated into a clinical risk-scoring tool, with each factor assigned a weighting on the basis of its respective regression coefficient 38, 40 . The calculated overall score represents a patient's risk of having evidence of a pseudotumor, with higher scores associated with increased risk (see Appendix). P values of <0.05 were considered significant. (Table I) C ompared with the nonpseudotumor group, the pseudotumor group was younger (p = 0.0286), was more commonly female (63.9% versus 38.2%; p < 0.001), and had a longer follow-up time (mean, 5.8 versus 4.8 years; p < 0.001). There were significant differences in MoMHR implant design between groups (p = 0.022). Receiver operating characteristic (ROC) curve to assess discrimination of the final multivariable model for identifying patients with evidence of a pseudotumor.
Results
Patient Factors
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Radiographic Factors (Table II Logistic Regression (Table III) Five factors (female sex, high acetabular component inclination, acetabular osteolysis, femoral osteolysis, and acetabular component loosening) significantly predicted being in the pseudotumor group in both the univariable and multivariable logistic regression analyses, and 2 factors (acetabular component anteversion of ‡5°and heterotopic ossification) significantly predicted being in the nonpseudotumor group. Young patient age at the time of radiography (p = 0.044) was a significant predictor of being in the pseudotumor group in the univariable analysis, although it was not significant in the multivariable analysis.
Internal Validation of the Final Multivariable Model
The final multivariable model was well calibrated (p = 0.589; Fig. 1 ) and demonstrated good discriminatory ability, with an area under the curve (AUC) of 0.801 (95% CI, 0.752 to 0.849; sensitivity = 74.4% and specificity = 71.7%; Fig. 2 ). Bootstrap validation of the final model provided a bias-corrected AUC of 0.784.
Clinical Risk Scoring Tool (Table IV) A clinical points-based risk tool for identifying patients with evidence of a pseudotumor was developed using the final multivariable model. High overall scores represented an increased risk of pseudotumor. Validation of the overall risk score model demonstrated that it had good discriminatory ability (AUC = 0.796; 95% CI, 0.747 to 0.845). The optimal risk score threshold for identifying MoMHRs with evidence of a pseudotumor was 18 points or more (95% CI, 11.9 to 24.1 points), which had 80.8% sensitivity and 65.2% specificity.
Discussion
O ur study demonstrated that a combination of patient and radiographic factors provided useful information for distinguishing between MoMHRs with and without evidence of a pseudotumor. Patient and radiographic factors predictive of MoMHRs with evidence of a pseudotumor included female sex, acetabular component malposition, acetabular osteolysis, femoral osteolysis, acetabular loosening, and the absence of heterotopic ossification. Surgeons may wish to consider these factors before proceeding with cross-sectional imaging.
Our findings suggest that radiographs form an important part of the assessment of MoMHR patients. The high AUC of the final model (0.801; bias-corrected, 0.784) confirms that a combination of patient and radiographic factors was useful for distinguishing between MoMHRs with and without evidence of a pseudotumor. Previous studies are limited by their assessment of only a few radiographic factors, such as cup 
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position or neck narrowing [10] [11] [12] [13] 34 . By contrast, the current study assessed all major radiographic parameters, and it is further strengthened by having a large control group with both symptomatic and asymptomatic patients who had no evidence of a pseudotumor on cross-sectional imaging. These patients with nonrevised MoMHRs are typical of the many patients currently under regular surveillance worldwide 18 . The final multivariable model identified female sex as the only patient factor significantly predicting MoMHRs with evidence of a pseudotumor. This finding is consistent with the literature 1,2,12,41 and further highlights the importance of stratifying MoMHR patients by sex for surveillance 18, 42 . Although we recognize that certain MoMHR designs have higher failure rates 1, 2, 12 , the present study did not identify implant design as a significant predictor of pseudotumor revision. This may reflect the limited number of different implant designs and the small numbers of certain implant designs that were included in the present study. However, we agree with previous recommendations that it is important to consider implant design when making clinical decisions about MoMHR patients 18, 42 . Similar to the authors of previous studies [10] [11] [12] , we identified high inclination and inadequate anteversion (<5°) as predictors of pseudotumor revision. Hard-on-hard bearings have low tolerance for acetabular component positioning outside an optimal zone, with such malposition associated with edge-loading, high bearing wear, and early failure 11 . However, the relationship between acetabular component position and pseudotumors is complex. Our study and 2 others 10,11 observed that MoMHRs revised for pseudotumor more commonly have acetabular components positioned in inadequate anteversion. Nonetheless, we recognize that other authors report excessive anteversion to be more important 12 . In addition, pseudotumors in patients with adequately positioned acetabular components have been reported in both our study (46% of the pseudotumor group; Table II) and previous studies 11, 12, 43 . Furthermore, a number of patients with well-functioning MoMHRs have malpositioned acetabular components 15, 16, 44, 45 . Although 63% of our nonpseudotumor group had abnormal findings on radiographs, which appears high, acetabular component malposition was the primary reason for these abnormalities. When all radiographic abnormalities apart from malposition are considered, only 19% of our nonpseudotumor group had abnormal findings on radiographs. Other studies have similarly reported abnormal radiographic findings (excluding malposition) in up to 25% of nonrevised MoMHRs 15, 16, 44, 45 . These observations suggest that pseudotumor development is multifactorial and not solely dependent on acetabular component malposition. It is therefore important to assess radiographs for other signs suggestive of failure.
Osteolysis (femoral and acetabular) and acetabular component loosening were highly predictive of MoMHRs with pseudotumors in this study. Previous reports observed intraoperative osteolysis in up to 33% of MoMHRs revised for pseudotumor and acetabular loosening in up to 28% 17, 46 . Furthermore, extensive osteolysis can require complex reconstruction, which may contribute to poor short-term outcomes following revision for pseudotumor 21, 47, 48 . Surgeons must therefore carefully inspect MoMHR radiographs for subtle osteolysis or acetabular loosening and arrange further investigations as necessary, as early identification of pseudotumors may improve patient outcomes following revision.
The clinical importance of femoral neck narrowing remains unclear. In well-functioning MoMHRs, narrowing has been observed in up to 77% of cases, with up to 28% having >10% narrowing 15, 16, 30, 34 . Longitudinal studies have reported that femoral neck narrowing stabilizes in well-functioning MoMHR patients within 5 years 16, 30, 34 . Therefore, it has been suggested that neck narrowing is a normal process reflecting early bone remodeling 13, 15 . However, neck narrowing has also been reported in up to 26% of MoMHRs revised for pseudotumor 9, 17 . We observed similar degrees of femoral neck narrowing in MoMHRs with and without pseudotumors. This suggests that femoral neck narrowing does not necessarily represent an underlying pseudotumor. However, if narrowing is observed, it must be interpreted in the context of other abnormalities.
Radiographic heterotopic ossification was more common in MoMHRs without evidence of a pseudotumor. The heterotopic ossification rate in the nonpseudotumor group (15.7%) was much lower than previous observations (up to 59%) 49 . As heterotopic ossification is more common in males 49 , we suspect that the higher rates observed in our nonpseudotumor group are related to significantly more males having well-functioning MoMHRs 15, 16, 41 . We recognize that other factors may also contribute to differences in heterotopic ossification rates, including surgical approach and nonsteroidal anti-inflammatory drug use during the postoperative period. However, these factors were not assessed because of a lack of medication data and the risk of overfitting our multivariable model. It is possible that patients with heterotopic ossification have a lower pseudotumor risk because the associated stiffness and reduced hip motion may decrease the risk of edge-loading and subsequent pseudotumor formation; however, this requires further investigation.
Current worldwide follow-up recommendations for MoMHR patients have recently been reported to be costly and not evidence-based 18 . The use of radiographs during follow-up has been somewhat overlooked because of the use of blood metal ion analysis and cross-sectional imaging 18 , with some authorities not specifying a role for radiographs 6 . The final study model and clinical risk scoring tool contained relevant patient and radiographic factors that are useful for distinguishing between MoMHRs with and without evidence of a pseudotumor. Our study therefore demonstrates that radiographs comprise an important part of the assessment of MoMHR patients, and we urge all regulatory authorities to include radiographs in their follow-up recommendations. Our findings may be particularly useful in centers where follow-up resources may need to be rationed given the costly nature of MoMHR surveillance 18 as well as in centers where access to blood metal ion analysis and cross-sectional imaging is limited. However, radiographs should not be considered a substitute for performing blood metal ion analysis and obtaining crosssectional imaging, given that 20% of our revised MoMHRs had normal findings on radiographs despite having histologically confirmed pseudotumors. Furthermore, our findings require validation prior to any clinical implementation 50 . This study has limitations, such as being retrospective and potentially not applicable to other MoMHR designs. Furthermore, the radiographs assessed in the pseudotumor group were taken significantly later after the primary MoMHR compared with nonpseudotumor patients, which should be considered when interpreting our findings. Given limitations with radiographic data (49% of MoMHRs had adequatequality immediate postoperative radiographs), this study cannot make conclusive statements about femoral neck narrowing. It is important to also acknowledge that this study only predicts the presence or absence of a pseudotumor at the time of radiographic assessment, and not the subsequent development of a pseudotumor, which would require a longitudinal study. Our final model requires validation in an external cohort; however, robust internal validation techniques were employed and the final model was not overfitted.
In conclusion, a combination of patient and radiographic factors provided useful information for distinguishing between MoMHRs with and without evidence of a pseudotumor. Surgeons may wish to consider these patient and radiographic factors predictive of pseudotumor (including female sex, acetabular component malposition, osteolysis, acetabular loosening, and the absence of heterotopic ossification) before proceeding with crosssectional imaging. Radiographs are important when assessing MoMHR patients and should be included in the follow-up recommendations issued by all regulatory authorities.
